Groundbreaking new treatment for aggressive breast cancer has 100% survival rate
Hope is on the horizon for patients with aggressive, inherited breast cancers. A recent clinical trial, led by researchers at Cambridge University, explored the effects of combining chemotherapy with the targeted cancer drug olaparib before surgery. Every patient who received this protocol survived the critical three-year post-treatment period. BRCA cancers are notoriously aggressive and difficult … Read more